Kokubo, Osaka
Fumio Kokubo, Osaka JP
Patent application number | Description | Published |
---|---|---|
20100135028 | LIGHT EMITTING DEVICE AND LIGHTING DEVICE HAVING THE SAME - A light-emitting device ( | 06-03-2010 |
20110032707 | LENS BODY, LIGHT SOURCE UNIT AND LIGHTING SYSTEM - Substantially cylindrical supporting units are formed at both sides of a lens. The supporting units are to adjust the separation distance between the lens and the surface of a substrate depending on the height dimension of a light emitting diode mounted on the substrate from the substrate face when the lens body is fixed to the substrate. A cylindrical convex part is formed at a part of the tip face of the supporting unit in a concentric fashion relative to the supporting unit, and a cylindrical positioning unit is formed at a part of the tip face of the convex part in a concentric fashion. The positioning unit functions as a member for positioning when the substrate and the lens body are fixed to each other. | 02-10-2011 |
20120014133 | LIGHT SOURCE MODULE AND ELECTRONIC DEVICE INCLUDING THE SAME - According to a light source module of the present invention, a plurality of light guides ( | 01-19-2012 |
20130250187 | DISPLAY DEVICE AND TELEVISION RECEIVER - An object of the present invention is to obtain a display device having excellent display quality by appropriately modifying the chromaticity of images. In this display device, a correction processing part (CPU | 09-26-2013 |
Masaya Kokubo, Osaka JP
Patent application number | Description | Published |
---|---|---|
20090118279 | COMPOUND CONTAINING BASIC GROUP AND USE THEREOF - The present invention relates to a compound represented by formula (I): | 05-07-2009 |
20090169567 | BASIC GROUP-CONTAINING COMPOUND AND USE THEREOF - A compound represented by general formula (I): | 07-02-2009 |
20090192182 | COMPOUND HAVING ACIDIC GROUP WHICH MAY BE PROTECTED, AND USE THEREOF - A compound represented by general formula (I): | 07-30-2009 |
20090325992 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF - A compound represented by general formula (I): | 12-31-2009 |
20120156219 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF - The compound represented by formulae (I) and (II), the salt thereof, the N-oxide thereof or the solvate thereof, or the prodrug thereof and the pharmaceutical composition comprising thereof have a CXCR4-regulating effect, and they are effective in treatment and prevention of various inflammatory disease, various allergic disease, acquired immunodeficiency syndrome infection with human immunodeficiency virus, or agents for regeneration therapy. | 06-21-2012 |
20120207765 | CHEMOKINE RECEPTOR ANTAGONISTS AND USE THEREOF - A compound represented by general formula (I): | 08-16-2012 |
20120328627 | CHEMOKINE RECEPTOR ANTAGONISTS AND USE THEREOF - The present invention relates to a compound represented by formula (I): | 12-27-2012 |
20130245074 | NOVEL COMPOUND AND MEDICAL USE THEREOF - Provided is a levodopa prodrug that overcomes the problems attributed to the blood kinetics of levodopa such as large number of doses and the incidence of side effects due to frequent dosing. (2S)-2-Amino-3-(3,4-bis((2-(benzoyloxy)-2-methylpropanoyl)oxy)phenyl)propanoic acid, a salt thereof, or a solvate thereof is a levodopa prodrug, and provides a flat blood concentration-time profile of levodopa through oral administration, and therefore is useful as a preventive and/or therapeutic agent for Parkinson's disease and/or Parkinson's syndrome that overcomes the problems associated with pharmaceutical preparations of levodopa. | 09-19-2013 |
20140072576 | CHEMOKINE RECEPTOR ANTAGONISTS AND USE THEREOF - The present invention relates to a compound represented by formula (I): | 03-13-2014 |
20140187630 | NOVEL COMPOUND AND MEDICAL USE THEREOF - Provided is a levodopa prodrug that overcomes the problems attributed to the blood kinetics of levodopa such as large number of doses and the incidence of side effects due to frequent dosing. (2S)-2-Amino-3-(3,4-bis((2-(benzoyloxy)-2-methylpropanoyl)oxy)phenyl)propanoic acid, a salt thereof, or a solvate thereof is a levodopa prodrug, and provides a flat blood concentration-time profile of levodopa through oral administration, and therefore is useful as a preventive and/or therapeutic agent for Parkinson's disease and/or Parkinson's syndrome that overcomes the problems associated with pharmaceutical preparations of levodopa. | 07-03-2014 |
Tadashi Kokubo, Osaka JP
Patent application number | Description | Published |
---|---|---|
20080227905 | Thermoplastic Elastomer Composition - The object of the present invention is to provide a thermoplastic elastomer composition having a good balance between the hardness and the mechanical strength, exhibiting superior rubber elasticity, high-temperature creep characteristics and formability in a wide range of temperature, and having oil resistance and heat resistance. The thermoplastic elastomer composition comprises (A) (meth)acrylic block copolymer; (B) a compound containing at least two amino groups in its molecule; and (C) a thermoplastic resin. The (meth)acrylic block copolymer (A) comprises (A1) a (meth)acrylic copolymer block and (A2) an acrylic copolymer block. A1 least one of the polymer blocks has at least one acid anhydride group. The (meth)acrylic block copolymer (A) and the compound (B) are dynamically vulcanized in the thermoplastic resin (C). | 09-18-2008 |
Toshio Kokubo, Osaka JP
Patent application number | Description | Published |
---|---|---|
20090136502 | Preventives/Remedies for Cancer - The present invention provides a drug containing a substance that inhibits a function of RET, such as an antibody against RET. In addition, the present invention provides a drug containing a substance that inhibits a function of GDNF, such as an antibody against GDNF. Moreover, the present invention provides a drug containing a substance that inhibits a function of GFRα1, such as an antibody against GFRα1. The drug of the present invention is useful as an agent for the prophylaxis or treatment of breast cancer and the like, an inhibitor of cancer cell growth and the like. | 05-28-2009 |